Given that miR-346, -361-3p and -197 have profound effects on AR protein levels and activity in PC cells, we hypothesised that modulation of these miRs may alter PC cell proliferation, and that miR inhibition may demonstrate combinatorial effects with AR silencing, potentially revealing a novel therapeutic avenue for PC treatment. The gene discussed is AR; the disease is pachyonychia congenita.